E178 - 2023 NEI Synapse Extended Q&A: 5HT2A with Dr. Thomas Schwartz

Dr. Thomas Schwartz, a specialist in psychopharmacology, tackles audience questions on serotonin 5HT2A. He discusses the potential of Pima Vanserin in managing visual hallucinations related to psychosis and dementia. Schwartz explores the dual role of mirtazapine in movement disorders and weight control, along with its effects on sleep architecture. He also addresses the promising combination of mirtazapine and venlafaxine for depression when SSRIs fall short. Finally, he highlights innovative approaches to treating dystonia, emphasizing serotonin 2A antagonism as a new avenue.